Skip to main content
Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
5.38
+0.18 (3.46%)
At close: Mar 9, 2026, 4:00 PM EDT
5.28
-0.10 (-1.86%)
After-hours: Mar 9, 2026, 4:35 PM EDT

Bicycle Therapeutics Revenue

Bicycle Therapeutics had revenue of $11.73M in the quarter ending September 30, 2025, with 338.49% growth. This brings the company's revenue in the last twelve months to $28.34M, down -23.20% year-over-year. In the year 2024, Bicycle Therapeutics had annual revenue of $35.28M with 30.76% growth.

Revenue (ttm)
$28.34M
Revenue Growth
-23.20%
P/S Ratio
13.01
Revenue / Employee
$92,915
Employees
305
Market Cap
373.20M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202435.28M8.30M30.76%
Dec 31, 202326.98M12.51M86.52%
Dec 31, 202214.46M2.77M23.65%
Dec 31, 202111.70M1.31M12.58%
Dec 31, 202010.39M-3.41M-24.72%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Ginkgo Bioworks Holdings 170.16M
Foghorn Therapeutics 24.52M
LENZ Therapeutics 17.50M
Aclaris Therapeutics 7.83M
Absci 2.82M
Shattuck Labs 1.00M
Neurogene 925.00K
Revenue Rankings

BCYC News

More News